Back to FAYEZ SAROFIM & CO FAYEZ SAROFIM & CO

NVONVO

Showing 8 of 31 quarters

Position history for FAYEZ SAROFIM & COFAYEZ SAROFIM & CO's holdings in Novo Nordisk A/S

Yes. Fayez Sarofim holds 2,924,500 shares of NVO (Novo Nordisk), worth $140.2M, as of its Q2 2026 13F filing. It reduced the position by 470,979 shares (-13.9%) from Q1 2026. Fayez Sarofim has held NVO in every 13F on record since Q4 2018, 31 quarterly filings. NVO is 0.3% of Fayez Sarofim's reported 13F portfolio.

Current Value

$140.2M

Current Shares

2.9M

Total Value Change

-$1.3B

Total Shares Change

-9.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
2.9M
-13.9%
$140.2M0.3%$47.34
0
2026-Q1
Decreased
3.4M
-19.8%
$124.8M0.3%$36.29
0
2025-Q4
Decreased
4.2M
-42.4%
$215.5M0.5%$48.46
0
2025-Q3
Decreased
7.4M
-30.0%
$408.1M0.9%$52.85
0
2025-Q2
Decreased
10.5M
-6.3%
$725M1.7%$65.01
0
2025-Q1
Decreased
11.2M
-1.5%
$778.6M1.9%$65.40
0
2024-Q4
Decreased
11.4M
-6.8%
$979.3M2.4%$79.73
0
2024-Q3
Decreased
12.2M
-2.7%
$1.5B3.7%$110.37
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used